Anti‐inflammatory and immune‐mediated therapy for a case of febrile infection‐related epilepsy syndrome with rapid recurrence
Author(s) -
Kurimoto Tomonori,
Matsuoka Tsuyoshi,
Ami Yuki,
Kanno Koji,
Fujii Takashi,
Fujiwara Naoki,
Matsuoka Takashi
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5952
Subject(s) - medicine , etiology , epilepsy , refractory (planetary science) , disease , immune system , epilepsy syndromes , intensive care medicine , immunology , pediatrics , psychiatry , physics , astrobiology
Febrile infection‐related epilepsy syndrome (FIRES) is a disease of unknown etiology, characterized by refractory frequent focal seizures, which require prolonged intensive care. We successfully treated a boy with FIRES with anti‐inflammatory and immunosuppressive therapy. This case suggests that an autoimmune mechanism may play a role in the development of FIRES.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom